Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis-Reference-Cited by-同舟云学术

Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis

Published:2020-01-28 Issue:6 Volume:9 Page:2085-2095
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Deng Qinfang¹²,Fang Qiyu¹²,Sun Hui²,Singh Aditi P.³,Alexander Mariam³^ORCID,Li Shenduo⁴,Cheng Haiying³,Zhou Songwen²

Affiliation:

1. Department of Oncology The Third Affiliated Hospital of Soochow University Changzhou China

2. Department of Oncology Shanghai Pulmonary Hospital Tongji University School of Medicine Shanghai China

3. Department of Oncology Montefiore Medical Center Albert Einstein College of Medicine Bronx NY USA

4. Department of Medicine Jacobi Medical Center Bronx NY USA

Funder

Fundamental Research Funds for the Central Universities

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2869

Reference19 articles.

1. World Health Organization.Cancer fact sheet.2018.https://www.who.int/news-room/fact-sheets/detail/cancer

2. Surveillance Epidemiology and End Results (SEER) Program.Cancer stat facts: lung and bronchus cancer.

3. Network NCC.NCCN clinical practice guidelines in oncology (NCCN Guidelines®): non‐small cell lung cancer. Version 4.2018—April 26 2018.2018. Available fromhttps://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf

4. Circulating DNA in EGFR-mutated lung cancer

5. Circulating tumor DNA in non–small‐cell lung cancer: a primer for the clinician;Singh AP;JCO Precis Oncol,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. When not having a tissue may not be an issue in advanced lung cancer;Chinese Clinical Oncology;2023-08

2. Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer;Frontiers in Oncology;2023-07-12

3. Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications;International Journal of Molecular Sciences;2023-06-28

4. Molecular patterns of egyptian patients with non-squamous non-small-cell lung cancers: a clinicopathological study;Journal of the Egyptian National Cancer Institute;2023-04-03

5. Can Liquid Biopsy Based on ctDNA/cfDNA Replace Tissue Biopsy for the Precision Treatment of EGFR-Mutated NSCLC?;Journal of Clinical Medicine;2023-02-10